Warfarin and Kionex Patient

Discharge Diagnoses:

1. Gram negative septic shock, E.coli

2. Hypotensive syncope, GLF, C2 fx, rib fx

3. C2 cervical fracture due to GLF/syncope due to hypotension/shock

4. Metabolic Encephalopathy 5. Atrial fibrillation with RVR

6. Right heart failure

7. Pulmonary hypertension

8. Urinary tract infection, present on admission

9. Hyperkalemia

10. Rib fractures, right 6-8

11. Acute kidney injury

12. Aortic stenosis, Mild

13. Mitral stenosis, Mild

14. Scalp laceration

15. Oral thrush

16. Cellulitis of left foot

My input:

Would it have been better to prescribe Macrobid 100 mg because of DD interaction of bactrim with warfarin, (Her INR went up from 2.4 to 2.6 in one day) informed the ID doctor about the possibility of switching the medication. Will look in to sensitivtiy labs

Little bit about Kionex:

FDA use: Hyperkalemia

Hyperkalemia Adult Dose

Average dosage, 15 to 60 g/day given as 15 g orally once to 4 times daily; dosage and duration dependent on the severity and resistance of hyperkalemia (Oral suspension)
Average dosage, 30 to 50 g rectally every 6 hours; dosage and duration dependent on the severity and resistance of hyperkalemia (Rectal suspension)

Comments

Mounjaro, Is it a game changer for weight loss and diabetes?

MOUNJARO™ ( Tirzepatide) was approved for medical use in the United States in May 2022 WEIGHT LOSS: (Not approved by FDA for weight loss) Eli Lilly and Company is finalizing an application to the U.S. Food and Drug Administration for fast-track approval to sell tirzepatide for chronic weight management. MOUNJARO™ is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist indicated in adults for type 2 diabetes mellitus management. CONTRAINDICATIONS Personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2 Known serious all to tirzepatide or any of the excipients in MOUNJARO ...

Respiratory syncytial virus (RSV) ---cough

Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease in young children. Recent RSV strain in Utah is causing moderate to severe cough (especially during night), weakness and cold-like symptoms . RSV infection is sometimes severe and is associated with hospitalization, mechanical ventilation, long-term complications, decreased quality of life, loss of work productivity and patient/caregiver stress. RSV may cause inflammation and infection of small airways and lungs. Recovery time usually ranges from 7 to 14 days, but RSV can cause serious disease. RSV combined with increasing flu circulation are keeping some hospitals and pharmacies occupied. Seventeen states are reporting that more than 80% of beds are full, according to the data. Children’s hospitals in Utah, Arizona, the District of Columbia, Maine, Minnesota, Rhode Island, and Kentucky are almost completely at capacity. RSV can spread when viral droplets from a ...

Sodium chloride Tablets USP

A 91- year old patient. Admitted to the hospital from the ED. Patient was seen for altered mental status. Labs, CT of brain head, CXR XR of left Tib/Fib were performed. Presumed meningioma in the left middle cranial fossa was noted. Sodium was critically low at 114. Nephrologist was consulted and hyponatremia is of unknown etiology. Patient also has uncontroled hypertension. Comorbidities: Coronary artery disease, Diabetes, Dementia, hypothyroidism, hyperlipedemia, neuropathy. Patient will need physicain oversight for hyponatremia, normal saline routinely, and medication management for hypertension. Rx: Sodium Chloride USP 1.0 gram Use 1. Hyponatremia 2. Preparation of normal isotonic solution of sodium chloride 3. As an electrolyte replenisher for the prevention of heat cramps, due to excessive perspiration 4. any alternate use as directed by a physician Each tablet contains: sodium 394mg Hyponatremia is a common electrolyte disorder encountered i...

Real Time Pharmacology

Search This Blog